蔚藍鋰芯(002245.SZ):收到政府補助資金合計1736.35萬元
格隆匯10月7日丨蔚藍鋰芯(002245.SZ)公佈,公司全資控股的下屬公司天鵬鋰能技術(淮安)有限公司(以下簡稱"天鵬鋰能")於近日收到江蘇淮安清江浦經濟開發區財政和資產管理局撥付的產業扶持資金合計1,000.00萬元;控股子公司淮安澳洋順昌光電技術有限公司(以下簡稱"淮安光電")於近日收到淮安市清江浦區財政支付中心撥付的市級及區級企業補助資金合計736.35萬元。上述補助資金均系與資產相關的政府補助,天鵬鋰能及淮安光電已實際收到款項並確認為遞延收益。上述政府補助不具有可持續性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.